Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q2 2024 vs. Q1 2024
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 14 | 16 | +2 |
| Shares | 1.62M | 1.81M | +188.7K (+11.6%) |
| Value | $2.30M | $996.1K | −$1.31M (−56.8%) |
New holders (4)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 15,199 | $8.36K | 0.00% |
| Endowment Wealth Management, Inc. | 14,307 | $7.87K | 0.01% |
| Jones Financial Companies LLLP | 6,000 | $3.30K | 0.00% |
| Bank of America Corp | 151 | $83 | 0.00% |
Sold out (2)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Vontobel Holding Ltd. | 12,000 | $17.0K |
| Wells Fargo & Company | 134 | $190 |